Literature DB >> 22994850

Carvacrol together with TRPC1 elimination improve functional recovery after traumatic brain injury in mice.

Maximilian Peters1, Victoria Trembovler, Alexander Alexandrovich, Moshe Parnas, Lutz Birnbaumer, Baruch Minke, Esther Shohami.   

Abstract

Death of Central Nervous System (CNS) neurons following traumatic brain injury (TBI) is a complex process arising from a combination of factors, many of which are still unknown. It has been found that inhibition of transient receptor potential (TRP) channels constitutes an effective strategy for preventing death of CNS neurons following TBI. TRP channels are classified into seven related subfamilies, most of which are Ca(2+) permeable and involved in many cellular functions, including neuronal cell death. We hypothesized that TRP channels of the TRPC subfamily may be involved in post-TBI pathophysiology and that the compound 5-isopropyl-2-methylphenol (carvacrol), by inhibition of TRP channels, may exert neuroprotective effect after TBI. To test these suppositions, carvacrol was given to mice after TBI and its effect on their functional recovery was followed for several weeks. Our results show that neurological recovery after TBI was significantly enhanced by application of carvacrol. To better define the type of the specific channel involved, the effect of carvacrol on the extent and speed of recovery after TBI was compared among mice lacking TRPC1, TRPC3, or TRPC5, relative to wild type controls. We found that neurological recovery after TBI was significantly enhanced by combining carvacrol with TRPC1 elimination, but not by the absence of TRPC3 or TRPC5, showing a synergistic effect between carvacrol application and TRPC1 elimination. We conclude that TRPC1-sensitive mechanisms are involved in TBI pathology, and that inhibition of this channel by carvacrol enhances recovery and should be considered for further studies in animal models and humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994850      PMCID: PMC3521132          DOI: 10.1089/neu.2012.2575

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  32 in total

1.  Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity.

Authors:  Honghong Yao; Fuwang Peng; Navneet Dhillon; Shannon Callen; Sirosh Bokhari; Lisa Stehno-Bittel; S Omar Ahmad; John Q Wang; Shilpa Buch
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

Review 2.  Pharmacology of vanilloid transient receptor potential cation channels.

Authors:  Joris Vriens; Giovanni Appendino; Bernd Nilius
Journal:  Mol Pharmacol       Date:  2009-03-18       Impact factor: 4.436

3.  Final report on the safety assessment of sodium p-chloro-m-cresol, p-chloro-m-cresol, chlorothymol, mixed cresols, m-cresol, o-cresol, p-cresol, isopropyl cresols, thymol, o-cymen-5-ol, and carvacrol.

Authors:  Alan Andersen
Journal:  Int J Toxicol       Date:  2006       Impact factor: 2.032

4.  Evidence that TRPC1 is involved in hippocampal glutamate-induced cell death.

Authors:  K Lakshmi Narayanan; Krithi Irmady; Srinivasa Subramaniam; Klaus Unsicker; Oliver von Bohlen und Halbach
Journal:  Neurosci Lett       Date:  2008-12-03       Impact factor: 3.046

5.  Attenuation of store-operated Ca2+ current impairs salivary gland fluid secretion in TRPC1(-/-) mice.

Authors:  Xibao Liu; Kwong Tai Cheng; Bidhan C Bandyopadhyay; Biswaranjan Pani; Alexander Dietrich; Biman C Paria; William D Swaim; David Beech; Eda Yildrim; Brij B Singh; Lutz Birnbaumer; Indu S Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

6.  TRPC3 channels are required for synaptic transmission and motor coordination.

Authors:  Jana Hartmann; Elena Dragicevic; Helmuth Adelsberger; Horst A Henning; Martin Sumser; Joel Abramowitz; Robert Blum; Alexander Dietrich; Marc Freichel; Veit Flockerzi; Lutz Birnbaumer; Arthur Konnerth
Journal:  Neuron       Date:  2008-08-14       Impact factor: 17.173

7.  Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels.

Authors:  Moshe Parnas; Maximilian Peters; Daniela Dadon; Shaya Lev; Irena Vertkin; Inna Slutsky; Baruch Minke
Journal:  Cell Calcium       Date:  2009-01-09       Impact factor: 6.817

Review 8.  Physiology and pathophysiology of canonical transient receptor potential channels.

Authors:  Joel Abramowitz; Lutz Birnbaumer
Journal:  FASEB J       Date:  2008-10-21       Impact factor: 5.191

9.  Induced TRPC1 expression sensitizes intestinal epithelial cells to apoptosis by inhibiting NF-kappaB activation through Ca2+ influx.

Authors:  Bernard S Marasa; Jaladanki N Rao; Tongtong Zou; Lan Liu; Kaspar M Keledjian; Ai-hong Zhang; Lan Xiao; Jie Chen; Douglas J Turner; Jian-Ying Wang
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

10.  Overexpression of TRPC3 increases apoptosis but not necrosis in response to ischemia-reperfusion in adult mouse cardiomyocytes.

Authors:  Dan Shan; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Cell Physiol       Date:  2008-01-09       Impact factor: 4.249

View more
  9 in total

1.  TRPC1- and TRPC3-dependent Ca2+ signaling in mouse cortical astrocytes affects injury-evoked astrogliosis in vivo.

Authors:  Thabet Belkacemi; Alexander Niermann; Laura Hofmann; Ulrich Wissenbach; Lutz Birnbaumer; Petra Leidinger; Christina Backes; Eckart Meese; Andreas Keller; Xianshu Bai; Anja Scheller; Frank Kirchhoff; Stephan E Philipp; Petra Weissgerber; Veit Flockerzi; Andreas Beck
Journal:  Glia       Date:  2017-06-21       Impact factor: 7.452

Review 2.  Role of TRP channels in the cardiovascular system.

Authors:  Zhichao Yue; Jia Xie; Albert S Yu; Jonathan Stock; Jianyang Du; Lixia Yue
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-21       Impact factor: 4.733

Review 3.  Neuroprotective effects of carvacrol against Alzheimer's disease and other neurodegenerative diseases: A review.

Authors:  Zahra Azizi; Nahid Majlessi; Samira Choopani; Nasser Naghdi
Journal:  Avicenna J Phytomed       Date:  2022 Jul-Aug

Review 4.  Traumatic brain injury using mouse models.

Authors:  Yi Ping Zhang; Jun Cai; Lisa B E Shields; Naikui Liu; Xiao-Ming Xu; Christopher B Shields
Journal:  Transl Stroke Res       Date:  2014-02-05       Impact factor: 6.829

5.  A biocompatible "split luciferin" reaction and its application for non-invasive bioluminescent imaging of protease activity in living animals.

Authors:  Aurélien Godinat; Ghyslain Budin; Alma R Morales; Hyo Min Park; Laura E Sanman; Matthew Bogyo; Allen Yu; Andreas Stahl; Elena A Dubikovskaya
Journal:  Curr Protoc Chem Biol       Date:  2014-09-09

6.  A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice.

Authors:  Aurélien Godinat; Hyo Min Park; Stephen C Miller; Ke Cheng; Douglas Hanahan; Laura E Sanman; Matthew Bogyo; Allen Yu; Gennady F Nikitin; Andreas Stahl; Elena A Dubikovskaya
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

7.  The Outwardly Rectifying Current of Layer 5 Neocortical Neurons that was Originally Identified as "Non-Specific Cationic" Is Essentially a Potassium Current.

Authors:  Omer Revah; Lior Libman; Ilya A Fleidervish; Michael J Gutnick
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

8.  The anti-inflammatory properties of Satureja khuzistanica Jamzad essential oil attenuate the effects of traumatic brain injuries in rats.

Authors:  Elham Abbasloo; Fatemeh Dehghan; Mohammad Khaksari; Hamid Najafipour; Reza Vahidi; Shahriar Dabiri; Gholamreza Sepehri; Gholamreza Asadikaram
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

9.  The TRPC6 inhibitor, larixyl acetate, is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction.

Authors:  Xingjuan Chen; Natalie N Taylor-Nguyen; Ashley M Riley; B Paul Herring; Fletcher A White; Alexander G Obukhov
Journal:  J Neuroinflammation       Date:  2019-01-31       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.